1. Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials. (1st January 2019) Authors: Strober, B.E.; Gottlieb, A.B.; van de Kerkhof, P.C.M.; Puig, L.; Bachelez, H.; Chouela, E.; Imafuku, S.; Thaçi, D.; Tan, H.; Valdez, H.; Gupta, P.; Kaur, M.; Frajzyngier, V.; Wolk, R. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials3. (10th October 2018) Authors: Strober, B.E.; Gottlieb, A.B.; van de Kerkhof, P.C.M.; Puig, L.; Bachelez, H.; Chouela, E.; Imafuku, S.; Thaçi, D.; Tan, H.; Valdez, H.; Gupta, P.; Kaur, M.; Frajzyngier, V.; Wolk, R. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Changes in C‐reactive protein in patients with moderate‐to‐severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy. (15th January 2014) Authors: Strober, B.E.; Poulin, Y.; Teller, C.; Wang, Y.; Williams, D.A.; Goldblum, O.M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 12(2014:Dec.) Page Start: 1701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Defining drug‐free remission of skin disease in patients with plaque psoriasis. (1st June 2020) Authors: Armstrong, A.W.; Blauvelt, A.; Crowley, J.J.; Gordon, K.B.; Krueger, G.G.; Krueger, J.G.; Sobell, J.M.; Strober, B.E.; Srivastava, B.; Menter, A. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Defining drug‐free remission of skin disease in patients with plaque psoriasis. (29th January 2020) Authors: Armstrong, A.W.; Blauvelt, A.; Crowley, J.J.; Gordon, K.B.; Krueger, G.G.; Krueger, J.G.; Sobell, J.M.; Strober, B.E.; Srivastava, B.; Menter, A. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases. (21st December 2012) Authors: de Souza, A.; Ali‐Shaw, T.; Reddy, S.M.; Fiorentino, D.; Strober, B.E. Journal: British journal of dermatology Issue: Volume 168:Number 1(2013:Jan.) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate‐to‐severe plaque psoriasis. (1st February 2018) Authors: Strober, B.E.; Langley, R.G.B.; Menter, A.; Magid, M.; Porter, B.; Fox, T.; Safi, J.; Papavassilis, C. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate‐to‐severe plaque psoriasis. (22nd December 2017) Authors: Strober, B.E.; Langley, R.G.B.; Menter, A.; Magid, M.; Porter, B.; Fox, T.; Safi, J.; Papavassilis, C. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prioritizing the global research agenda in psoriasis: an International Psoriasis Council Delphi consensus exercise. (1st January 2016) Authors: Strober, B.E.; Griffiths, C.E.M.; O'Dell, S.J.; Tebbey, P.W.; Barker, J.N.W.N. Journal: British journal of dermatology Issue: Volume 174:Number 1(2016) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prioritizing the global research agenda in psoriasis: an International Psoriasis Council Delphi consensus exercise. (8th November 2015) Authors: Strober, B.E.; Griffiths, C.E.M.; O'Dell, S.J.; Tebbey, P.W.; Barker, J.N.W.N. Journal: British journal of dermatology Issue: Volume 174:Number 1(2016) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗